Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes

被引:61
|
作者
McClure, Nathan S. [1 ]
Al Sayah, Fatima [1 ]
Ohinmaa, Arto [1 ]
Johnson, Jeffrey A. [1 ]
机构
[1] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada
关键词
EQ-5D-5L; health state preference; minimally important difference; type; 2; diabetes; QUALITY-OF-LIFE; RESPONSIVENESS;
D O I
10.1016/j.jval.2018.02.007
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: The EuroQol five-dimensional questionnaire (EQ-5D) is a generic preference-based measure of health-related quality of life, and several studies have made attempts to estimate the minimally important difference (MID) for the EQ-5D index score. Objectives: To estimate the MID of the five-level EQ-5D (EQ-5D-5L) index score in a population-based sample of adults with type 2 diabetes and to explore whether the MID estimate varies by baseline index score and the direction of change in health status. Methods: We used longitudinal survey data of adults with type 2 diabetes in Alberta, Canada. The EQ-5D-5L MID was estimated first by the instrument defined approach, which used the difference between the baseline index scores and the index scores of simulated single-level transitions, and then by the anchor-based approach, which categorized 1-year changes in depressive symptoms, diabetes-related distress, as well as physical and mental health functioning into no change, small change, and large change groups, wherein the MID was estimated as the average change in index score of the small change group. Results: Using the instrument-defined approach, MID estimates were 0.043, 0.040, and 0.045, whereas anchor-based MID estimates were 0.042, 0.034, and 0.049 for all change, improvement, and deterioration, respectively. Larger MID estimates were observed for lower baseline index scores and for deterioration in health status. Conclusions: MID estimates of the EQ-5D-5L index score were consistent between instrument-defined and anchor-based approaches and ranged between 0.03 and 0.05. Estimates varied by baseline index score and the direction of change, with similar results for patient subgroups.
引用
收藏
页码:1090 / 1097
页数:8
相关论文
共 50 条
  • [1] Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores
    McClure, Nathan S.
    Al Sayah, Fatima
    Xie, Feng
    Luo, Nan
    Johnson, Jeffrey A.
    VALUE IN HEALTH, 2017, 20 (04) : 644 - 650
  • [2] The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients
    Pan, Chen-Wei
    Sun, Hong-Peng
    Wang, Xingzhi
    Ma, Qinghua
    Xu, Yong
    Luo, Nan
    Wang, Pei
    QUALITY OF LIFE RESEARCH, 2015, 24 (07) : 1767 - 1774
  • [3] Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes
    Al Sayah, Fatima
    Qiu, Weiyu
    Xie, Feng
    Johnson, Jeffrey A.
    QUALITY OF LIFE RESEARCH, 2017, 26 (08) : 2057 - 2066
  • [4] Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients
    Siriwardana, Amanda N.
    Hoffman, Anna T.
    Morton, Rachael L.
    Smyth, Brendan
    Brown, Mark A.
    VALUE IN HEALTH, 2024, 27 (04) : 469 - 477
  • [5] The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients
    Chen-Wei Pan
    Hong-Peng Sun
    Xingzhi Wang
    Qinghua Ma
    Yong Xu
    Nan Luo
    Pei Wang
    Quality of Life Research, 2015, 24 : 1767 - 1774
  • [6] Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes
    Fatima Al Sayah
    Weiyu Qiu
    Feng Xie
    Jeffrey A. Johnson
    Quality of Life Research, 2017, 26 : 2057 - 2066
  • [7] Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols
    Henry, Edward B.
    Barry, Luke E.
    Hobbins, Anna P.
    McClure, Nathan S.
    O'Neill, Ciaran
    VALUE IN HEALTH, 2020, 23 (07) : 936 - 944
  • [8] Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease
    Tsai, Amy Po Yu
    Hur, Seo Am
    Wong, Alyson
    Safavi, Mohsen
    Assayag, Deborah
    Johannson, Kerri A.
    Morisset, Julie
    Fell, Charlene
    Fisher, Jolene H.
    Manganas, Helene
    Shapera, Shane
    Cox, Gerard
    Gershon, Andrea S.
    Hambly, Nathan
    Khalil, Nasreen
    To, Teresa
    Wilcox, Pearce George
    Halayko, Andrew
    Kolb, Martin R. J.
    Ryerson, Christopher J.
    THORAX, 2021, 76 (01) : 37 - 43
  • [9] Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer
    Bourke, Siobhan
    Bennett, Bryan
    Oluboyede, Yemi
    Li, Tara
    Longworth, Louise
    O'Sullivan, Sian Bissell
    Braverman, Julia
    Soare, Ioana-Alexandra
    Shaw, James W.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2024, 22 (01)
  • [10] A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes
    Matza, Louis S.
    Boye, Kristina S.
    Stewart, Katie D.
    Curtis, Bradley H.
    Reaney, Matthew
    Landrian, Amanda S.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2015, 13